Wednesday, February 22, 2017 2:23 PM / NSE
This is to notify the General Public that the Board of Directors of GlaxoSmithKline Consumer Nigeria plc will meet on Wednesday 9th March 2017 to consider and approve:
1. The 2016 Audited Financial Statements
2. The amount to be recommended to members as dividend at the next Annual General Meeting
3. Fix the date and venue of the Annual General Meeting.
The General Public will be informed of the Board’s decision immediately after the meeting.
The General Public should take note that the closed period for dealing in the Company’s securities by the Directors, Managers or connected persons commenced on 10th February 2017 and shall terminate on Wednesday 15th March 2017.